Related Experiment Video

Updated: Aug 19, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

[Molecular epidemiology of chronic hepatitis C (HCV) virus]

Jadwiga Nitkiewicz1

  • 1Molecular Virology Division, Pathology Department, Columbia University, New York, NY 10019, USA. jbn2101@columbia.edu

Przeglad Epidemiologiczny
|February 26, 2005
PubMed

Insights

Hepatitis C virus (HCV) was identified 15 years ago, but its pathogenesis and replication remain unclear. Understanding HCV's genetic diversity is crucial for developing effective treatments and diagnostics.

Area of Science:

  • Virology
  • Molecular Biology
  • Hepatology

Context:

  • Hepatitis C virus (HCV) is a primary cause of chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
  • HCV identification was challenging, requiring direct genome sequencing after initial immunologic and virologic techniques failed.
  • Despite its identification 15 years ago, the pathogenesis and replication mechanisms of HCV are not fully understood.

Purpose:

  • To review the molecular biology of Hepatitis C virus.
  • To highlight the genetic heterogeneity and quasi-species nature of HCV.
  • To discuss the implications of HCV genetic variation on disease progression and treatment response.

Summary:

  • HCV was identified through direct genome sequencing, advancing molecular biology studies using recombinant proteins and DNA techniques.
  • HCV exhibits significant genetic heterogeneity, circulating as 'quasi-species' within hosts and varying globally into at least six major genotypes.
  • Subtype prevalence differs geographically, influencing viral pathogenicity and response to interferon therapy.

Impact:

  • Advances in understanding HCV molecular biology and genetic diversity.
  • Provides insights into the challenges of HCV diagnosis and treatment due to its quasi-species nature.
  • Emphasizes the need for genotype-specific treatment strategies for improved patient outcomes in Hepatitis C management.

More Related Videos

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA04:11

Real-Time Polymerase Chain Reaction-Based Detection and Quantification of Hepatitis B Virus DNA

Published on: December 15, 2023

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis10:23

Lipid Droplet Isolation for Quantitative Mass Spectrometry Analysis

Published on: April 17, 2017

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material for adaptive...
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...